𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dealing with multiplicities in pharmacoepidemiologic studies

✍ Scribed by William F. Rosenberger


Book ID
102660445
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
520 KB
Volume
5
Category
Article
ISSN
1053-8569

No coin nor oath required. For personal study only.

✦ Synopsis


The problem of multiplicities arises in almost all aspects of scientific studies. When multiple hypotheses are tested in a study, one must adjust the significance level of individual tests to maintain an overall probability error rate. The reasons for this are explored in a non-technical way. Techniques for dealing with multiplicities are described and motivated and guidelines are given, with implications for both study design and publication. KEY WORDS -confidence interval estimation; multiple testing problem; p-values; probability error rate; tests of hypothesis; type I error PRELUDE This article discusses statistical hypothesis testing and confidence interval estimation, including the concepts of null and alternative hypotheses, rejection region, type I error, a-level (also called type I error rate or significance level), p-value, and Confidence interval estimation. Any standard statistics textbook will give a good review.'


πŸ“œ SIMILAR VOLUMES


Sample size for cohort studies in pharma
✍ A. D. McMahon; T. M. MacDonald πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

Object Ð Cohort studies in pharmacoepidemiology can result in a unique type of study, where subjects have complex types of exposure to drugs (with periods of non-exposure as well). The object of this paper is to explain how to calculate the sample size of such a study. Method Ð It is assumed that a

Statistical issues in pharmacoepidemiolo
✍ Deborah Ashby; Rosalind L. Smyth; Philip J. Brown πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

Pharmacoepidemiology is the study of the use and the effect of drugs in large numbers of people. The work relies largely on standard epidemiological principles, which, applied in a new context, bring particular constraints and opportunities. In January 1994, a cluster of children with cystic fibrosi